INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 75 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 3.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $5,000 | -37.5% | 1,250 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $8,000 | -20.0% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $10,000 | +25.0% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $8,000 | -11.1% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $9,000 | -25.0% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $12,000 | 0.0% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $12,000 | +9.1% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $11,000 | +37.5% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $8,000 | +14.3% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $7,000 | -30.0% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $10,000 | 0.0% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $10,000 | -9.1% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $11,000 | -8.3% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $12,000 | -14.3% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $14,000 | – | 1,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sante Capital Fund, LP | 115,637 | $1,072,000 | 0.44% |
| Defender Capital, LLC. | 135,466 | $1,255,000 | 0.42% |
| Green Alpha Advisors, LLC | 62,566 | $580,000 | 0.40% |
| Harvest Investment Services, LLC | 51,239 | $474,000 | 0.20% |
| SEVEN EIGHT CAPITAL, LP | 118,270 | $1,096,000 | 0.15% |
| Cedar Brook Financial Partners, LLC | 54,500 | $505,000 | 0.15% |
| WASATCH ADVISORS LP | 3,576,706 | $33,156,000 | 0.14% |
| Banco BTG Pactual S.A. | 20,000 | $185,000 | 0.12% |
| Keystone Financial Group | 60,712 | $563,000 | 0.10% |
| Virtus ETF Advisers LLC | 25,105 | $233,000 | 0.10% |